Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules

Biology Direct

Volumn 4, Issue , 2009, Pages 31-

  Dressel, Ralf ^a   Guan, Kaomei ^a   Nolte, Jessica ^a   Elsner, Leslie ^a   Monecke, Sebastian ^a   Nayernia, Karim ^a,b   Hasenfuss, Gerd ^a   Engel, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; PEPTIDE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SERPINB9 PROTEIN, MOUSE;

AGING; ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; IMMUNOLOGY; INJECTION; MALE; METABOLISM; MOUSE; MOUSE MUTANT; MULTIPOTENT STEM CELL; PATHOLOGY; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPERMATOZOON; TEMPERATURE; TERATOMA;

AGING; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; INJECTIONS; MALE; MEMBRANE PROTEINS; MICE; MICE, SCID; MULTIPOTENT STEM CELLS; PEPTIDES; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SERPINS; SPERMATOZOA; T-LYMPHOCYTES, CYTOTOXIC; TEMPERATURE; TERATOMA;

MUS;

EID: 71049168277     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-4-31     Document Type: Article

References (67)

1. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680. 10.1016/j.cell.2008.02.008, 18295582.
2. Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, Kato T, Kazuki Y, Toyokuni S, Toyoshima M, Niwa O, Oshimura M, Heike T, Nakahata T, Ishino F, Ogura A, Shinohara T. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004, 119:1001-1012. 10.1016/j.cell.2004.11.011, 15620358.
3. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, Nolte J, Wolf F, Li M, Engel W, Hasenfuss G. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006, 440:1199-1203. 10.1038/nature04697, 16565704.
4. Seandel M, James D, Shmelkov SV, Falciatori I, Kim J, Chavala S, Scherr DS, Zhang F, Torres R, Gale NW, Yancopoulos GD, Murphy A, Valenzuela DM, Hobbs RM, Pandolfi PP, Rafii S. Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 2007, 449:346-350. 10.1038/nature06129, 17882221.
5. Ko K, Tapia N, Wu G, Kim JB, Bravo MJ, Sasse P, Glaser T, Ruau D, Han DW, Greber B, Hausdorfer K, Sebastiano V, Stehling M, Fleischmann BK, Brustle O, Zenke M, Scholer HR. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell 2009, 5:87-96. 10.1016/j.stem.2009.05.025, 19570517.
6. Cinalli RM, Rangan P, Lehmann R. Germ cells are forever. Cell 2008, 132:559-562. 10.1016/j.cell.2008.02.003, 18295574.
7. Guan K, Wolf F, Becker A, Engel W, Nayernia K, Hasenfuss G. Isolation and cultivation of stem cells from adult mouse testes. Nat Protoc 2009, 4:143-154. 10.1038/nprot.2008.242, 19180086.
8. Zovoilis A, Nolte J, Drusenheimer N, Zechner U, Hada H, Guan K, Hasenfuss G, Nayernia K, Engel W. Multipotent adult germline stem cells and embryonic stem cells have similar microRNA profiles. Mol Hum Reprod 2008, 14:521-529. 10.1093/molehr/gan044, 18697907.
9. Zechner U, Nolte J, Wolf M, Shirneshan K, Hajj NE, Weise D, Kaltwasser B, Zovoilis A, Haaf T, Engel W. Comparative methylation profiles and telomerase biology of mouse multipotent adult germline stem cells and embryonic stem cells. Mol Hum Reprod 2009, 15:345-353. 10.1093/molehr/gap023, 19297418.
10. Guan K, Wagner S, Unsold B, Maier LS, Kaiser D, Hemmerlein B, Nayernia K, Engel W, Hasenfuss G. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 2007, 100:1615-1625. 10.1161/01.RES.0000269182.22798.d9, 17478732.
11. Glaser T, Opitz T, Kischlat T, Konang R, Sasse P, Fleischmann BK, Engel W, Nayernia K, Brüstle O. Adult germ line stem cells as a source of functional neurons and glia. Stem Cells 2008, 26:2434-2443. 10.1634/stemcells.2008-0163, 18635869.
12. Streckfuss-Bömeke K, Vlasov A, Hülsmann S, Yin D, Nayernia K, Engel W, Hasenfuss G, Guan K. Generation of functional neurons and glia from multipotent adult mouse germ-line stem cells. Stem Cell Res 2009, 2:139-154. 10.1016/j.scr.2008.09.001, 19383419.
13. Mardanpour P, Guan K, Nolte J, Lee JH, Hasenfuss G, Engel W, Nayernia K. Potency of germ cells and its relevance for regenerative medicine. J Anat 2008, 213:26-29. 10.1111/j.1469-7580.2008.00930.x, 18565110.
14. Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, Aicher W, Buhring HJ, Mattheus U, Mack A, Wagner HJ, Minger S, Matzkies M, Reppel M, Hescheler J, Sievert KD, Stenzl A, Skutella T. Generation of pluripotent stem cells from adult human testis. Nature 2008, 456:344-349. 10.1038/nature07404, 18849962.
15. Kossack N, Meneses J, Shefi S, Nguyen HN, Chavez S, Nicholas C, Gromoll J, Turek PJ, Reijo-Pera RA. Isolation and Characterization of Pluripotent Human Spermatogonial Stem Cell-Derived Cells. Stem Cells 2009, 27:138-149. 10.1634/stemcells.2008-0439, 2729695, 18927477.
16. Golestaneh N, Kokkinaki M, Pant D, Jiang J, Destefano D, Fernandez-Bueno C, Rone JD, Haddad BR, Gallicano GI, Dym M. Pluripotent Stem Cells Derived from Adult Human Testes. Stem Cells Dev 2009,
17. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
18. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324. 10.1038/nature05944, 17554336.
19. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526, 18029452.
20. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002, 2:859-871. 10.1038/nri934, 12415309.
21. Saric T, Frenzel LP, Hescheler J. Immunological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs 2008, 188:78-90. 10.1159/000118784, 18303241.
22. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008, 9:725-729. 10.1038/nrm2466, 18698329.
23. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008, 132:544-548. 10.1016/j.cell.2008.02.009, 18295571.
24. Boghaert ER, Sridharan L, Khandke KM, Armellino D, Ryan MG, Myers K, Harrop R, Kunz A, Hamann PR, Marquette K, Dougher M, DiJoseph JF, Damle NK. The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. Int J Oncol 2008, 32:221-234.
25. Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev 2002, 188:136-146. 10.1034/j.1600-065X.2002.18812.x, 12445287.
26. Dressel R, Schindehütte J, Kuhlmann T, Elsner L, Novota P, Baier PC, Schillert A, Bickeböller H, Herrmann T, Trenkwalder C, Paulus W, Mansouri A. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS ONE 2008, 3:e2622. 10.1371/journal.pone.0002622, 2440803, 18612432.
27. Abdullah Z, Saric T, Kashkar H, Baschuk N, Yazdanpanah B, Fleischmann BK, Hescheler J, Krönke M, Utermöhlen O. Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J Immunol 2007, 178:3390-3399.
28. Voss AK, Thomas T, Gruss P. Germ line chimeras from female ES cells. Exp Cell Res 1997, 230:45-49. 10.1006/excr.1996.3418, 9013705.
29. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 1993, 90:8424-8428. 10.1073/pnas.90.18.8424, 47369, 8378314.
30. Cheng J, Dutra A, Takesono A, Garrett-Beal L, Schwartzberg PL. Improved generation of C57BL/6J mouse embryonic stem cells in a defined serum-free media. Genesis 2004, 39:100-104. 10.1002/gene.20031, 15170695.
31. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007, 25:1177-1181. 10.1038/nbt1335, 17724450.
32. Nayernia K, Li M, Jaroszynski L, Khusainov R, Wulf G, Schwandt I, Korabiowska M, Michelmann HW, Meinhardt A, Engel W. Stem cell based therapeutical approach of male infertility by teratocarcinoma derived germ cells. Hum Mol Genet 2004, 13:1451-1460. 10.1093/hmg/ddh166, 15163638.
33. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994, 76:17-27. 10.1016/0092-8674(94)90169-4, 8287475.
34. Dressel R, Raja SM, Höning S, Seidler T, Froelich CJ, von Figura K, Günther E. Granzyme-mediated cytotoxicity does not involve the mannose 6-phosphate receptors on target cells. J Biol Chem 2004, 279:20200-20210. 10.1074/jbc.M313108200, 14985351.
35. Dressel R, Elsner L, Quentin T, Walter L, Günther E. Heat shock protein 70 is able to prevent heat shock-induced resistance of target cells to CTL. J Immunol 2000, 164:2362-2371.
36. Oulad-Abdelghani M, Bouillet P, Decimo D, Gansmuller A, Heyberger S, Dolle P, Bronner S, Lutz Y, Chambon P. Characterization of a premeiotic germ cell-specific cytoplasmic protein encoded by Stra8, a novel retinoic acid-responsive gene. J Cell Biol 1996, 135:469-477. 10.1083/jcb.135.2.469, 2121034, 8896602.
37. Baltus AE, Menke DB, Hu YC, Goodheart ML, Carpenter AE, de Rooij DG, Page DC. In germ cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication. Nat Genet 2006, 38:1430-1434. 10.1038/ng1919, 17115059.
38. Zhou Q, Li Y, Nie R, Friel P, Mitchell D, Evanoff RM, Pouchnik D, Banasik B, McCarrey JR, Small C, Griswold MD. Expression of stimulated by retinoic acid gene 8 (Stra8) and maturation of murine gonocytes and spermatogonia induced by retinoic acid in vitro. Biol Reprod 2008, 78:537-545. 10.1095/biolreprod.107.064337, 18032419.
39. Anderson EL, Baltus AE, Roepers-Gajadien HL, Hassold TJ, de Rooij DG, van Pelt AM, Page DC. Stra8 and its inducer, retinoic acid, regulate meiotic initiation in both spermatogenesis and oogenesis in mice. Proc Natl Acad Sci USA 2008, 105:14976-14980. 10.1073/pnas.0807297105, 2542382,2542382, 18799751.
40. Joly E, Oldstone MB. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 1992, 8:1185-1190. 10.1016/0896-6273(92)90138-4, 1610569.
41. Ljunggren HG, Paabo S, Cochet M, Kling G, Kourilsky P, Karre K. Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis. J Immunol 1989, 142:2911-2917.
42. Powis SJ, Townsend AR, Deverson EV, Bastin J, Butcher GW, Howard JC. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 1991, 354:528-531. 10.1038/354528a0, 1758495.
43. Medema JP, de Jong J, Peltenburg LT, Verdegaal EM, Gorter A, Bres SA, Franken KL, Hahne M, Albar JP, Melief CJ, Offringa R. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 2001, 98:11515-11520. 10.1073/pnas.201398198, 58761, 11562487.
44. Balaji KN, Schaschke N, Machleidt W, Catalfamo M, Henkart PA. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 2002, 196:493-503. 10.1084/jem.20011836, 2196055, 12186841.
45. Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 2007, 1:253-258. 10.1016/j.stem.2007.07.019, 18371359.
46. Koch CA, Geraldes P, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells 2008, 26:89-98. 10.1634/stemcells.2007-0151, 17962705.
47. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008, 100:133-158. full_text, 18620095.
48. Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27:1050-1056. 10.1002/stem.37, 19415771, 2733374.
49. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci USA 2007, 104:20920-20925. 10.1073/pnas.0710265105, 2409242, 18093946.
50. Tian L, Catt JW, O'Neill C, King NJ. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod 1997, 57:561-568. 10.1095/biolreprod57.3.561, 9282991.
51. Bonde S, Zavazava N. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 2006, 24:2192-2201. 10.1634/stemcells.2006-0022, 16794265.
52. Magliocca JF, Held IK, Odorico JS. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 2006, 15:707-717. 10.1089/scd.2006.15.707, 17105406.
53. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J 2007, 21:1345-1357. 10.1096/fj.06-6769com, 17284483.
54. Wu DC, Boyd AS, Wood KJ. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 2008, 26:1939-1950. 10.1634/stemcells.2008-0078, 18535153.
55. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 2002, 200:249-258. 10.1046/j.1469-7580.2002.00030.x, 1570685, 12033729.
56. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002, 99:9864-9869. 10.1073/pnas.142298299, 125045, 12114532.
57. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004, 22:448-456. 10.1634/stemcells.22-4-448, 15277692.
58. Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev 2008, 17:1023-1029. 10.1089/scd.2008.0091, 2657199, 18491958.
59. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV, Robbins RC. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005, 112:I166-172.
60. Wagner H, Starzinski-Powitz A, Rollinghoff M, Golstein P, Jakob H. T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia. J Exp Med 1978, 147:251-264. 10.1084/jem.147.1.251, 2184095, 415107.
61. Bikoff EK, Jaffe L, Ribaudo RK, Otten GR, Germain RN, Robertson EJ. MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon. Nature 1991, 354:235-238. 10.1038/354235a0, 1720508.
62. Brower RC, England R, Takeshita T, Kozlowski S, Margulies DH, Berzofsky JA, Delisi C. Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol 1994, 31:1285-1293. 10.1016/0161-5890(94)90079-5, 7969189.
63. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004, 5:524-530. 10.1038/ni1058, 15048111.
64. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996, 4:565-571. 10.1016/S1074-7613(00)80483-5, 8673703.
65. Frenzel LP, Abdullah Z, Kriegeskorte AK, Dieterich R, Lange N, Busch DH, Krönke M, Utermöhlen O, Hescheler J, Saric T. Role of NKG2D-ligands and ICAM-1 in NK cell-mediated Lysis of Murine Embryonic Stem Cells and Embryonic Stem Cell-derived Cardiomyocytes. Stem Cells 2009, 27:307-316. 10.1634/stemcells.2008-0528, 18988711.
66. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008, 26:389-420. 10.1146/annurev.immunol.26.021607.090404, 18304003.
67. Pipkin ME, Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007, 19:301-308. 10.1016/j.coi.2007.04.011, 17433871.